author-photo

Ann-Lii Cheng

National Taiwan University
National Health Research Institutes

839

Papers

35406

Citations

Citation Trend

Filter By

Papers (839) Sort By

Journal Conference Others

Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy.

2021 Journal of Cancer Research and Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma.

2021 Oncologist
Show All
- Source
- Cite
- Save
Citations (0)
Revisiting the Full Spectrum of Helicobacter pylori-Related Gastric Lymphoma

2021
Show All
- Source
- Cite
- Save
Citations (0)
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (11)
IMbrave150: Exploratory efficacy and safety results of hepatocellular carcinoma (HCC) patients (pts) with main trunk and/or contralateral portal vein invasion (Vp4) treated with atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in a global Ph III study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT.

2021 Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (1)
Pembrolizumab (pembro) vs placebo (pbo) in patients (pts) with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the randomized, phase III KEYNOTE-240 study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Safety and Efficacy of Cabozantinib for Patients with Advanced Hepatocellular Carcinoma and Child-Pugh B Liver Function: Retrospective Analysis From the CELESTIAL Randomised Controlled Trial

2021
Show All
- Source
- Cite
- Save
Citations (0)
Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma.

2021 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (0)